ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物科技指數ETF-iShares Nasdaq
216.40
+3.87
1.82%
盤後：
217.37
0.9700
+0.45%
16:01 EDT
成交量：
144.72萬
成交額：
3.13億
市值：
108.85億
市盈率：
34.28
高：
217.12
開：
213.40
低：
213.22
收：
212.53
52周最高：
217.12
52周最低：
137.09
股本：
5,030.00萬
流通股本：
5,030.00萬
量比：
0.68
換手率：
2.88%
股息：
0.40
股息率：
0.19%
每股收益(TTM):
6.31
每股收益(LYR):
-1.4940
淨資產收益率：
24.54%
總資產收益率：
0.10%
市淨率：
1.34
市盈率(LYR):
-144.85
資料載入中...
總覽
公司
新聞資訊
公告
歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態
美股速递
·
08/24
吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌
美股速递
·
08/24
美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。
智通财经
·
08/21
Piper Sandler上調安進目標價至457美元
格隆汇
·
08/21
美國研究綜述-安進、Analog Devices、莫德納
路透中文
·
08/20
復宏漢霖盤中漲近8% 近期聯手山德士出海至多10款生物類似藥
新浪港股
·
08/20
福泰製藥(VRTX)股票8月19日收盤上漲4.48%：釋放什麼信號？
TradingKey中文
·
08/20
吉利德科學(GILD)股票8月19日盤中上漲3.66%：背後推手曝光
TradingKey中文
·
08/20
安進(AMGN)股票8月19日盤中上漲3.19%：背後推手曝光
TradingKey中文
·
08/20
再生元製藥旗下Pasatru獲歐洲藥品管理局審評，全球申報在即
美股速递
·
08/20
再生元製藥獲FDA批准：Pasatru（Garetosmab-Grts）上市，治療成人進行性骨化性纖維發育不良
美股速递
·
08/20
異動解讀｜生物科技指數ETF-iShares Nasdaq盤中上漲5.1%，MNC併購加速疊加多重利好共振
行情直击
·
08/19
瑞穗上調安進目標價至352美元
格隆汇
·
08/19
駿利亨德森投資：專利到期倒逼藥企擴張 生物科技併購、IPO市場同步復甦
智通财经网
·
08/19
藥代違規進入診療區域！湘雅二醫院發藥品「停用函」，艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」
蓝鲸财经
·
08/19
TScan Therapeutics披露：安進將終止與其研究合作及許可協議
美股速递
·
08/19
吉利德科學(GILD)股票8月18日盤中上漲3.14%：背後推手曝光
TradingKey中文
·
08/19
argenx SE(ARGX)股票8月17日盤中上漲16.67%：關鍵驅動因素揭曉
TradingKey中文
·
08/18
EyePoint股價料將創下歷史最大跌幅，因其一款實驗性眼科藥物未能達到後期臨床試驗目標
路透中文
·
08/17
美股開盤 | 三大指數升跌不一，閃迪升逾3%，Argenx SE漲近9%
老虎资讯综合
·
08/17
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/IBB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":216.4,"timestamp":1787688000000,"preClose":212.53,"halted":0,"volume":1447206,"hourTrading":{"tag":"盘后","latestPrice":217.37,"preClose":216.4,"latestTime":"16:01 EDT","volume":827,"amount":179001.59457000002,"timestamp":1787688103603,"change":0.97,"changeRate":0.004482,"amplitude":0.004482},"delay":0,"changeRate":0.018209193996141744,"floatShares":50300000,"shares":50300000,"eps":6.311863,"marketStatus":"盤後交易","change":3.87,"latestTime":"08-25 16:03:27 EDT","open":213.4,"high":217.12,"low":213.22,"amount":312701736.82032,"amplitude":0.01835,"askPrice":217.44,"askSize":82,"bidPrice":215,"bidSize":10,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":212.53,"sharesOutstanding":49450000,"nav":213.623549,"aum":10681177450,"dividendRate":0.001866,"bidAskSpread":0.000342,"preHourTrading":{"tag":"盘前","latestPrice":213.19,"preClose":212.53,"latestTime":"09:29 EDT","volume":272,"amount":58020.02352,"timestamp":1787664595037,"change":0.66,"changeRate":0.003105,"amplitude":0.007293},"postHourTrading":{"tag":"盘后","latestPrice":217.37,"preClose":216.4,"latestTime":"16:01 EDT","volume":827,"amount":179001.59457000002,"timestamp":1787688103603,"change":0.97,"changeRate":0.004482,"amplitude":0.004482},"volumeRatio":0.679556,"impliedVol":0.2404,"impliedVolPercentile":0.6295},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50300000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.679556,"shares":50300000,"dividePrice":0.4038,"high":217.12,"amplitude":0.01835,"preClose":212.53,"low":213.22,"week52Low":137.09,"pbRate":"1.34","psRate":"261.88","week52High":217.12,"institutionHeld":0,"latestPrice":216.4,"committee":-0.782609,"eps":6.311863,"divideRate":0.001866,"volume":1447206,"delay":0,"ttmEps":6.311863,"open":213.4,"prevYearClose":168.77,"prevWeekClose":213.56,"prevMonthClose":186.41,"prevQuarterClose":190.19,"fiveDayClose":203.56,"twentyDayClose":190.52,"sixtyDayClose":172.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定，将吉利德科学（Gilead Sciences）旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域，且不再受限于患者的PD-L1表达状态。这一举措意味着，无论生物标志物检测结果如何，符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择，也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应，认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU1571399168.USD","LU1674673691.USD","LU0965509010.AUD","LU1934455194.USD","LU2087621335.USD","MEDI","LU0965509101.SGD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU2357627491.SGD","LU1585245621.USD","LU2112291526.USD","BK4532","LU0861579265.USD","BK4588","LU1066053197.SGD","LU1430594728.SGD","LU1037948541.HKD","LU0122379950.USD","LU2089984988.USD","LU1934455277.USD","BK4550","BBH","LU0823416689.USD","LU0965509283.SGD","LU0109394709.USD","TMED","SG9999015952.SGD","SG9999015986.USD","LU1057294990.SGD","IE00B19Z3581.USD","IE0002270589.USD","IE00BSNM7G36.USD","LU0889565916.HKD","BMED","BK4578","LU2468319806.SGD","SG9999015945.SGD","LU1934455863.HKD","LU2324357040.USD","LU1037948897.HKD","LU1023059063.AUD","SG9999015978.USD","LU1674673428.USD","BK4139","BIB","LU0114720955.EUR","TBXU","GILD","IE00B7SZLL34.SGD","LU0882574055.USD","BK4568","LU1061106388.HKD","LU1839511570.USD","LU0965508806.USD","LU0289739699.SGD","BK4566","BK4583","BK4585","IBB","IE00B3T34201.USD","LU0234570918.USD","LU0859254822.USD","LU1066051498.USD","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布，欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步，为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU0861579265.USD","LU0965508806.USD","LU1057294990.SGD","LU1066051498.USD","LU1778281490.HKD","LU0965509283.SGD","SG9999015952.SGD","BK4550","BK4585","LU1571399168.USD","LU2112291526.USD","LU1037948897.HKD","LU2357627491.SGD","LU0109394709.USD","LU1839511570.USD","TMED","IE00B3T34201.USD","BMED","BIB","LU1585245621.USD","LU0859254822.USD","BK4568","GILD","IE00B7SZLL34.SGD","IBBQ","LU0289739699.SGD","LU1037948541.HKD","BK4566","LU1674673691.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","TBXU","BBH","LU0234570918.USD","LU2089984988.USD","LU2087621335.USD","LU1061106388.HKD","LU1430594728.SGD","IE00BKVL7J92.USD","LU1066053197.SGD","LU0823416689.USD","LU1934455194.USD","BK4583","LU0965509010.AUD","IE0002270589.USD","LU0058720904.USD","BK4588","LU0882574055.USD","IE00B19Z3581.USD","SG9999015945.SGD","LU0889565916.HKD","LU2324357040.USD","IE00BZ1G4Q59.USD","LU1674673428.USD","LU1934455277.USD","LU1023059063.AUD","LU1934455863.HKD","BK4139","IE00BSNM7G36.USD","LU0122379950.USD","SG9999015986.USD","LU0114720955.EUR","SG9999015978.USD","BK4532","LU2468319806.SGD","BK4578","LU0965509101.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291370","title":"美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:49","pubTimestamp":1787327356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FTC","BIB","GXPC","EVNT","JHMT","DISC","PBS","TGRW","PNQI","LRGG","AMGN","IXP","IEME","RSPT","MSFY","XLCI","MNA","WEBL","TBXU","GXPT","GGTL","PJP","TDAQ","BCTK","ORCZ","KEMQ","MRGR","TRUC","WEBX","DRUP","PBE","CWC","QQMG","IHF","FCOM","ONEQ","NBDS","BUYO","IBB","IBBQ","MUSQ","NBCC","MSFX","ARB","BWEB","GOOX","BBH","HCA","JHCS","EMQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250489","title":"Piper Sandler上調安進目標價至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IBBQ","LU1571399168.USD","UDN","IE0002141913.USD","BK4533","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4534","LU2112291526.USD","BK4588","LU0122379950.USD","LU2089984988.USD","PBE","UUP","BBH","PJP","LU0109394709.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU1057294990.SGD","LU0889565916.HKD","BK4599","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4139","BIB","TBXU","LU1061106388.HKD","IE0009355771.USD","BK4581","LU0289739699.SGD","BK4566","IBB","BK4585","LU2242646821.SGD","AMGN","LU0320765992.SGD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043834","title":"美國研究綜述-安進、Analog Devices、莫德納","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043834","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660043834?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:49","pubTimestamp":1787212153,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Analog Devices、莫德纳路透8月20日-周四，华尔街证券分析师上调了多家在美国上市公司的评级和目标股价，其中包括安进、模拟设备公司和莫德纳。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4S44H0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360107168.USD","LU0052756011.USD","LU2089984988.USD","LU0511384066.AUD","LU1992135399.USD","SG9999015358.SGD","LU1074936037.SGD","LU0889565833.HKD","LU1929549753.HKD","LU2506951958.HKD","IE00BGHQF631.EUR","LU0823417737.USD","IE00BBT3K403.USD","XNTK","TGT","IE000M9KFDE8.USD","IE00BVYPNW00.USD","LU0882574055.USD","LU2468319806.SGD","FXL","LU0868494617.USD","LU1983299246.USD","LU2237443382.USD","LU0689472784.USD","PBE","BK4596","BK4551","BK4083","LU0472753341.HKD","LU0553294199.USD","IE00B775SV38.USD","HAKY","LU0130517989.USD","LU2517655374.HKD","SG9999015986.USD","LU0124676726.USD","LU2272731782.SGD","LU1267930227.SGD","LU2244417387.USD","IE00B19Z9Z06.USD","SG9999014013.SGD","LU0820561818.USD","IE000BZT7R73.USD","LU0823434583.USD","LU0289961442.SGD","SG9999014575.USD","LU0053666078.USD","IE00BFTCPJ56.SGD","ARTY","BK4560","IDNA","LU0477156953.USD","LU2347655156.SGD","LU2286300806.USD","SG9999015978.USD","BILL","LU0949170772.SGD","LU0690374615.EUR","SGXZ57979304.SGD","LU1941712264.USD","LU2491050154.USD","XLV","LU2125154935.USD","LU0158827948.USD","LU0310800379.SGD","LU0433182093.SGD","IBB","LU0077335932.USD","LU2506952170.USD","LU1303367103.USD","LU1670711040.USD","LU0823417653.USD","LU2129689605.HKD","LU2552382215.SGD","LU1066051225.USD","SG9999014021.USD","IE00B19Z3B42.SGD","LU1244550577.SGD","LU1934455194.USD","MRVU","LU1778281490.HKD","LU1066051498.USD","SG9999015945.SGD","IE0002141913.USD","LU0444973449.USD","IE000SO60NU8.SGD","LU0128525929.USD","FHLC","LU0081259029.USD","HRTS","MRNX","BK4559","DAT","LU2211815571.USD","LU2106854487.HKD","LU2125909916.SGD","LU1551013342.USD","IE00B3S45H60.SGD","LU1066051811.HKD","LU0070302665.USD","LU2517655291.USD","LU0719512351.SGD","LU1670710588.SGD","IE00BJT1NW94.SGD","LU0456855351.SGD","EL","MEDX","LU0094547139.USD","LU0648001328.SGD","LU0823421416.USD","LU0985489474.SGD","MVLL","IHE","LU0128525689.USD","LU1623119135.USD","TJX","LU2506951875.HKD","LU0187121727.USD","LU0106261372.USD","LU0320765646.SGD","IE00BZ9MQY76.HKD","LU2129689431.USD","MRK","LU2237443895.HKD","MRNY","IE0009356076.USD","LU0889565916.HKD","LU2517655028.SGD","LU0738911758.USD","LU2361044865.SGD","CRWL","LU1941712348.USD","LU2473716301.USD","LU0082616367.USD","LU1803068979.SGD","LU2265009873.SGD","LU1923623000.USD","BIB","BK4558","LU1923622614.USD","ADI","SG9999002232.USD","LU2347655073.USD","LU0820561909.HKD","LU0289739343.SGD","LU0274383776.USD","IXJ","LU1712237335.SGD","LU1430594728.SGD","LU0957808578.USD","LU1496350502.SGD","LU0124384867.USD","LU2237443622.USD","BK4585","CRWD","IE00BVYPNV92.GBP","LU0726765562.USD","LU2023250843.SGD","IE0002270589.USD","LU1988902786.USD","LU1064131342.USD","IE00BSNM7G36.USD","LU0312595415.SGD","LU0965509101.SGD","BK4503","LU1201861249.SGD","SNOW","LU0238689110.USD","BK4185","BK4581","LU0314106906.USD","BK4598","LU0056508442.USD","LU1978683503.SGD","BK4543","IE00BMPRXN33.USD","LU1989773731.SGD","BK4501","LU1023059063.AUD","LU2506952097.USD","IE00BZ1G4Q59.USD","BK4023","IE00BDGV0183.EUR","LU1670710661.SGD","LU0127658192.USD","LU0203347892.USD","LU1061106388.HKD","IE0000B7K699.USD","JDOC","LU0029864427.USD","LU0823434740.USD","GNOM","LU1861220033.SGD","LU2125909759.SGD","IE00BMPRXQ63.HKD","AIS","MRVL","WDNA","BK4505","IE00BN8TJ469.HKD","IE00B2B36J28.USD","BK4554","LU1261432733.SGD","IE000WAW04H5.SGD","BK4534","IGV","LU0689626769.HKD","FDTX","LU2931357623.SGD","IE00BMPRXR70.SGD","LU2357305700.SGD","LU0690374961.EUR","BK4592","LU1732799900.SGD","IE00B5949003.HKD","LU2552382132.HKD","LU0211327993.USD","BK4532","LU1989771016.USD","LU2433249047.HKD","LU2552382058.USD","LU2023250504.SGD","IE0004091025.USD","BK4516","FTXL","LU0198837287.USD","LU1917777945.USD","AMGN","LU1116320901.HKD","BK4613","LU2491050071.SGD","GLAM","LU1267930573.SGD","IE00BKVL7J92.USD","IE00BLSP4239.USD","LU0266013472.USD","LU1003077747.HKD","BK4533","LU0786609619.USD","LU2361044949.HKD","FAI","XDAT","LU0708994859.HKD","LU1316542783.SGD","BK4535","BK4007","LU2360107325.USD","LU2275660780.HKD","LU0795875086.SGD","LU1951198990.SGD","LU0265550946.USD","LU1839511570.USD","GDOC","LU1674673428.USD","IE0004086264.USD","BK4607","BK4512","IE000MB6IJN5.SGD","BK4604","LU0210528500.USD","LU1169590202.USD","LU1989764748.USD","IE0034235188.USD","LU0057025933.USD","CLOU","LU0868494708.USD","LU1235294995.USD","LU0211331839.USD","LU1093756325.SGD","SG9999013999.USD","PPH","LU0859254822.USD","LU0823411888.USD","BK4568","LU1923622291.USD","LU1496350171.SGD","WCBR","BK4114","LU1823568750.SGD","LOW","LU1861219969.SGD","LU1989764664.SGD","QQQA","LU2237443978.SGD","LU2360106780.USD","LU1861215975.USD","SG9999001176.SGD","LU0069063385.USD","TRUH","LU1670627923.USD","CIBR","LU2324357040.USD","LU1861214812.USD","LU2129689514.USD","HCA","LU0058720904.USD","LU0302445910.USD","BMED","LU0265550359.USD","LU2357627491.SGD","LU1291159041.SGD","LU1674673691.USD","LU0006306889.USD","LU1934455863.HKD","LU0061475181.USD","BK4588","LU2250418816.HKD","LU0985320562.USD","MRVX","IE00BD6J9T35.USD","BK4605","LU1244550221.USD","LU1267930490.SGD","PJP","BK4141","PAWZ","LU1974910355.USD","IE00B19Z9P08.USD","BK4504","SNOU","MRNA","LU1989772923.USD","LU0122379950.USD","LU0314104364.USD","SG9999002224.SGD","IE0004445239.USD","LU2461242641.AUD","BK4550","CRWC","LU1670711123.USD","SG9999014005.SGD","LU0878866978.SGD","LU2360032135.SGD","LU1551013425.SGD","LU0444971666.USD","SMHX","LU2272731865.HKD","LU1691799644.USD","FTXH","LU1506573853.SGD","LU1804176565.USD","LU0432979614.USD","BK4597","LU2242652126.USD","LU2125909247.SGD","SG9999003800.SGD","LU2290526834.HKD","IE0009355771.USD","WDAY","IE00BJJMRZ35.SGD","LU1046421795.USD","LU0861579265.USD","IE00B1BXHZ80.USD","AGNG","BK4094","TBXU","LU0098860793.USD","LU0114720955.EUR","LU0965508806.USD","BK4528","LU0109394709.USD","LU1718418525.SGD","DTCR","LU2237438978.USD","BK4548","LU2089283258.USD","BK4097","LU2298322129.HKD","SG9999000418.SGD","LU1852331112.SGD","IE000F7OJYX1.SGD","LU1720051108.HKD","LU2404859667.USD","LU0130102774.USD","LU1670628061.USD","BUG","LU2487616109.SGD","BK4183","IE00B42XCP33.USD","LU2361045086.USD","LU0950375773.USD","LU2355687059.USD","LU1989763005.USD","LU0203345920.USD","IHF","LU2458330169.SGD","LU1244550494.USD","IBBQ","SG9999001440.SGD","SG9999014542.SGD","LU1732800096.USD","LU0310799852.SGD","BBH","LU1035773651.USD","GTEK","IE00B894F039.SGD","WOLF","LU0068578508.USD","LU2041044095.USD","WISE","LU2264538146.SGD","IE00B4R5TH58.HKD","CLOD","IE00BLSP4452.SGD","LU0154236417.USD","SG9999015952.SGD","LU0912757837.SGD","WUGI","LU1935042991.SGD","VHT","LU1571399168.USD","LU2237443549.SGD","LGHT","LU2322448791.USD","LU0256863902.USD","BK4139","LU1116320737.USD","LU2322448957.HKD","LU1951200564.SGD","LU2087621335.USD","LU2272731600.USD","LU1642822529.SGD","LU0795875169.SGD","LU2023251221.USD","LU0661504455.SGD","LU1057294990.SGD","LU2098885051.SGD","SG9999011175.SGD","IE00BZ199S13.USD","LU2133065610.SGD","LU0642271901.SGD","SG9999014567.USD","LU2092937221.SGD","AIFD","LU2242646821.SGD","LU2237443465.HKD","SOXY","RXL","LU1162221912.USD","SG9999014559.SGD","LU1037948897.HKD","LU2298321311.HKD","LU0965509283.SGD","LU1992135472.HKD","LU0109392836.USD","LU0395794307.EUR","LU0289739699.SGD","LU1699723380.USD","IE00B5TLWC47.USD","LU0980610538.SGD","SG9999014039.USD","LU2360108059.USD","LU1037948541.HKD","LU2458330243.SGD","PSWD","LU1815336760.USD","ABBV","LU0943347566.SGD","LU0211328371.USD","LU0256863811.USD","LU0476273544.USD","SG9999001176.USD","LU2125909593.SGD","LU2491049909.HKD","SPAM","AIPI","IYH","LU0965509010.AUD","SNOY","LU0310800965.SGD","LU1066053197.SGD","LU2125154778.USD","SG9999015341.SGD","LU1069347547.HKD","LU1548497426.USD","BK4515","LU1119994496.HKD","LU1989772840.SGD","BK4599","LU1169589451.USD","LU1585245621.USD","IE00B19Z3581.USD","LU1084165304.USD","LU0208291251.USD","LU1934455277.USD","BK4566","LU0545039389.USD","LU0417517546.SGD","BK4130","LU0097036916.USD","LU1093756168.USD","LU2089985449.USD","LU1150488135.SGD","LU1720051017.SGD","LU2404859741.USD","LU0320765489.SGD","LU1150488218.USD","LU2112291526.USD","LU1935043536.SGD","IE00B3PB1722.GBP","BK4561","LU0942090050.USD","04332","LU2543165471.USD","LU0823421333.USD","LU0234572021.USD","LU0823416689.USD","BK4116","BK4155","LU2089284900.SGD","LU0170899867.USD","LU0234570918.USD","LU0320765992.SGD","LU0724618433.USD","PCTY","LU1489326972.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747701","title":"復宏漢霖盤中漲近8% 近期聯手山德士出海至多10款生物類似藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747701","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747701?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 10:56","pubTimestamp":1787194560,"startTime":"0","endTime":"0","summary":"模拟交易客户端复宏汉霖盘中涨近8%，截至发稿，股价上涨6.87%，现报70.05港元，成交额1646.58万港元。基于上述首批约定，山德士将向复宏汉霖支付首付款、相关里程碑付款及不可退还的选择权费共计至高3.22亿美元；2026年，复宏汉霖预计可达成的开票金额总计不超过1.005亿美元。值得一提的是，海外市场已成为复宏汉霖业绩增长的重要组成部分。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-20/doc-ininxqxw2099208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","LU2272731600.USD","IE00B5TLWC47.USD","LU2322448957.HKD","LU1992135399.USD","PPH","HK0000306685.HKD","HK0000320264.USD","LU2272731782.SGD","BK1161","LU2322448791.USD","HK0000165453.HKD","BK4588","LU2272731865.HKD","HK0000306701.USD","HK0000320223.HKD","LU1992135472.HKD","IBB","XPH","02696","LU2473716301.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473644","title":"福泰製藥(VRTX)股票8月19日收盤上漲4.48%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473644","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473644?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 04:16","pubTimestamp":1787170582,"startTime":"0","endTime":"0","summary":"• 在竞争对手临床试验宣告失败后，福泰制药股价飙升至历史新高。\n• 第二季度营收超出预期，公司同时上调了全年业绩指引。\n• 分析师纷纷给出看涨评级，平均目标价达 563.25 美元。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262119125-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","IBB","LU0234570918.USD","IDNA","BIB","IE00BJT1NW94.SGD","LU2462157665.USD","LU1674673428.USD","LU0256863811.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","SG9999001176.SGD","IE0009355771.USD","IE00B19Z3B42.SGD","BBH","LU0058720904.USD","LU0432979614.USD","LU2324357040.USD","LU2362541273.HKD","LU2456880835.USD","LU2468319806.SGD","PBE","IE0002270589.USD","LU0417517546.SGD","LU0109394709.USD","LU1674673691.USD","LU2417539215.USD","IE00B19Z9P08.USD","VRTX","LU1093756325.SGD","SGXZ57979304.SGD","LU0823416689.USD","LU1778281490.HKD","BK4567","BK4532","GNMX","IE00B19Z3581.USD","LU2236285917.USD","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU1585245621.USD","LU2237438978.USD","IE00B19Z9Z06.USD","LU2362541513.USD","BK4588","IBBQ","LU0320765992.SGD","TBXU","BK4139","LU1035775433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660113478","title":"吉利德科學(GILD)股票8月19日盤中上漲3.66%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660113478","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660113478?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 03:17","pubTimestamp":1787167048,"startTime":"0","endTime":"0","summary":"• 得益于HIV产品组合增长加速，吉利德上调了全年销售指引。\n• 联邦法院颁布禁令阻止海外进口，以保护其核心市场份额。\n• 分析师给予“买入”评级，平均目标价为157.79美元。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118864-market-movers-gild-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BIB","LU1839511570.USD","BK4139","LU1778281490.HKD","SG9999015952.SGD","LU0965509101.SGD","LU1585245621.USD","BBH","MEDI","LU1934455863.HKD","BK4550","LU0058720904.USD","BK4583","GILD","LU2468319806.SGD","IE00B19Z3581.USD","LU1934455194.USD","LU1066051498.USD","LU0965509010.AUD","BK4588","LU0320765992.SGD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU1934455277.USD","LU1023059063.AUD","LU0823416689.USD","BK4532","TMED","IE0002270589.USD","LU1037948541.HKD","LU1674673691.USD","SG9999015978.USD","TBXU","LU2324357040.USD","LU0289739699.SGD","IE00B7SZLL34.SGD","SG9999015945.SGD","LU1057294990.SGD","IE00BKVL7J92.USD","IBB","IBBQ","LU1674673428.USD","LU0965508806.USD","BK4578","IE00BZ1G4Q59.USD","LU0234570918.USD","SG9999015986.USD","BMED","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660819420","title":"安進(AMGN)股票8月19日盤中上漲3.19%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660819420","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660819420?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:16","pubTimestamp":1787163383,"startTime":"0","endTime":"0","summary":"• Argus上调安进目标价，并重申“买入”评级。\n• 第二季度财务业绩超出华尔街的营收和盈利预期。\n• 技术指标显示 MACD 买入信号及 RSI 买入条件。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118749-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4588","BK4139","IE00B2B36J28.USD","BK4581","PJP","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4534","LU0868494617.USD","LU1061106388.HKD","IE0009355771.USD","LU2089984988.USD","LU1983299246.USD","LU2242646821.SGD","SG9999001440.SGD","LU0109394709.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2242652126.USD","LU0889565916.HKD","BK4533","LU2468319806.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1023059063.AUD","BK4599","LU0289739699.SGD","BK4585","LU2112291526.USD","BIB","IBBQ","LU0122379950.USD","IE00BFTCPJ56.SGD","AMGN","IE00B4R5TH58.HKD","TBXU","BBH","PBE","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105025052","title":"再生元製藥旗下Pasatru獲歐洲藥品管理局審評，全球申報在即","url":"https://stock-news.laohu8.com/highlight/detail?id=1105025052","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105025052?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:00","pubTimestamp":1787162410,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布，其研发的药物Pasatru已被欧洲药品管理局纳入审评流程。与此同时，该公司正积极筹备在全球范围内提交该药物的上市申请。欧洲药品管理局的审评启动，为这款药物在欧洲地区的获批前景增添了重要砝码。业界分析认为，Pasatru若能顺利通过审评，有望为相关疾病领域带来新的治疗选择。再生元制药在创新药物研发领域深耕多年，此次针对Pasatru的全球布局，也彰显了其对这一候选药物商业潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","BK4139","LU1917777945.USD","LU1974910355.USD","IBB","LU0889565916.HKD","LU0289739699.SGD","LU0109394709.USD","LU2023250504.SGD","LU0114720955.EUR","LU2089984988.USD","LU0823434583.USD","TBXU","LU0058720904.USD","IBBQ","LU2362540622.SGD","LU2362541513.USD","BBH","LU2106854487.HKD","LU0320765992.SGD","REGN","LU2468319806.SGD","LU0823416689.USD","BK4585","LU2362541273.HKD","LU0823434740.USD","BK4588","LU0053666078.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188134905","title":"再生元製藥獲FDA批准：Pasatru（Garetosmab-Grts）上市，治療成人進行性骨化性纖維發育不良","url":"https://stock-news.laohu8.com/highlight/detail?id=1188134905","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188134905?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 01:59","pubTimestamp":1787162353,"startTime":"0","endTime":"0","summary":"再生元制药公司今日宣布，其研发的新药Pasatru已获得美国食品药品监督管理局的正式批准，用于治疗成人进行性骨化性纤维发育不良。这一罕见疾病此前一直缺乏有效的治疗手段，此次获批为患者带来了新的希望。FDA的此次批准基于多项临床研究数据，结果显示Pasatru在减缓异位骨化进展方面表现出显著疗效，且安全性可控。未来，再生元制药计划进一步拓展Pasatru的适应症范围，并探索其在其他相关疾病中的潜在应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2362540622.SGD","LU2106854487.HKD","LU0058720904.USD","BK4585","LU2362541513.USD","LU0823434583.USD","IBB","LU2089984988.USD","LU0823434740.USD","LU2237438978.USD","BBH","IBBQ","LU0289739699.SGD","REGN","LU0109394709.USD","LU2362541273.HKD","LU0053666078.USD","TBXU","LU0320765992.SGD","LU2468319806.SGD","LU0114720955.EUR","LU0823416689.USD","LU2023250504.SGD","BK4588","BK4139","LU1974910355.USD","LU1917777945.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187101531","title":"異動解讀｜生物科技指數ETF-iShares Nasdaq盤中上漲5.1%，MNC併購加速疊加多重利好共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1187101531","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187101531?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 22:09","pubTimestamp":1787148587,"startTime":"0","endTime":"0","summary":"8月19日，生物科技指数ETF-iShares Nasdaq盘中上涨5.1%，报213.88美元，成交额1.03亿美元。消息面上，生物科技板块近期迎来多重利好共振。另一方面，AI制药订单持续落地驱动生命科学上游需求攀升，板块整体景气度回暖。此外，再生元Libtayo获加拿大卫生部批准用于高危皮肤鳞状细胞癌辅助治疗，进一步提振市场情绪。该ETF追踪纳斯达克生物医疗指数，包含在纳斯达克上市的生物医疗公司，成分和权重可能随时间变化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660585446","title":"瑞穗上調安進目標價至352美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660585446","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660585446?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:55","pubTimestamp":1787129710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BIB","IE00B4R5TH58.HKD","LU2242646821.SGD","LU1571399168.USD","BK4585","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","BK4599","BBH","LU0868494617.USD","UUP","LU0058720904.USD","LU2468319806.SGD","IE0002141913.USD","BK4588","LU0320765992.SGD","LU0122379950.USD","AMGN","LU1023059063.AUD","LU2112291526.USD","PBE","LU0889565916.HKD","TBXU","LU1983299246.USD","LU0289739699.SGD","PJP","LU0109394709.USD","LU1057294990.SGD","BK4533","IE00B2B36J28.USD","LU2089984988.USD","BK4581","UDN","IBB","IBBQ","LU2242652126.USD","BK4534","IE00BJT1NW94.SGD","BK4566","IE00BJJMRZ35.SGD","SG9999001440.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431564","title":"駿利亨德森投資：專利到期倒逼藥企擴張 生物科技併購、IPO市場同步復甦","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431564","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431564?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:06","pubTimestamp":1787126785,"startTime":"0","endTime":"0","summary":"骏利亨德森投资称，尽管利率较市场年初的预期为高，但生物科技行业交易活动的增长动力持续不减。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IBB","BBC","BIB","BK4585","GTPE","MRNX","PBE","BBP","IYG","IAI","JDOC","MRNY","FBT","IWO","IJT","BK4582","SPCK","IBBJ","BK4588","QSML","BIS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660416851","title":"藥代違規進入診療區域！湘雅二醫院發藥品「停用函」，艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」","url":"https://stock-news.laohu8.com/highlight/detail?id=2660416851","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660416851?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 09:48","pubTimestamp":1787104101,"startTime":"0","endTime":"0","summary":"湘雅二医院方面向澎湃新闻表示，院方确有发该“协办函”。据此次公布的协办函，对几家涉事药企的处理决定颇为严厉。近年来，医药代表违规已不仅是行业道德问题，而是监管重点。此次湘雅二医院将企业列入购销负面清单，正是医院端落地上述政策的缩影。湘雅二医院相关负责人表示，自国家在2020年底建立医药代表备案制度，医院就积极响应国家政策，并不断完善内部制度和执行流程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787103396417327872","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4534","TBXU","IBBQ","LU0058720904.USD","PJP","BK4566","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0889565916.HKD","LU1057294990.SGD","LU2112291526.USD","LU2242652126.USD","LU0289739699.SGD","LU2242646821.SGD","IE0002141913.USD","PBE","BK4581","IE00B4R5TH58.HKD","LU1061106388.HKD","SG9999001440.SGD","BBH","IBB","LU0109394709.USD","BK4585","IE00B2B36J28.USD","BK0239","BK4139","BIB","688578","LU0320765992.SGD","LU2089984988.USD","LU0868494617.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4599","LU1571399168.USD","LU1983299246.USD","BK4533","LU2468319806.SGD","AMGN","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192416297","title":"TScan Therapeutics披露：安進將終止與其研究合作及許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1192416297","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192416297?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 05:04","pubTimestamp":1787087050,"startTime":"0","endTime":"0","summary":"值得注意的是，安进作为全球领先的生物制药公司，此举无疑将对TScan Therapeutics的研发管线及未来战略布局产生深远影响。TScan Therapeutics方面表示，将仔细评估这一变化对公司在研项目及整体运营带来的潜在影响。对于TScan Therapeutics而言，此番变故或许意味着需要重新校准其研发路径，并探索新的合作机会或资金来源以继续推进其创新疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","BK4534","BIB","IE00BJT1NW94.SGD","BK4533","BK4599","LU0289739699.SGD","BK4585","IE00B4R5TH58.HKD","IE0009355771.USD","LU1023059063.AUD","LU1983299246.USD","LU0889565916.HKD","BBH","LU0058720904.USD","LU2112291526.USD","LU2242646821.SGD","LU2468319806.SGD","PBE","TCRX","LU0109394709.USD","LU0868494617.USD","BK4581","IE00BJJMRZ35.SGD","BK4566","AMGN","BK4539","IE00B2B36J28.USD","PJP","SG9999001440.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0122379950.USD","LU1571399168.USD","BK4588","IBBQ","LU2089984988.USD","LU2242652126.USD","LU0320765992.SGD","TBXU","BK4139","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491619","title":"吉利德科學(GILD)股票8月18日盤中上漲3.14%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491619","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660491619?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 02:16","pubTimestamp":1787076999,"startTime":"0","endTime":"0","summary":"• 联邦法院禁令阻止了吉利德关键HIV药物的海外进口。\n• 强劲的基础业务营收增长与上调业绩指引提振了市场乐观情绪。\n• 肿瘤领域的战略投资及机构看涨期权活动的活跃支撑了股价的上涨势头。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262115765-market-movers-gild-20260818","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU1839511570.USD","LU1571399168.USD","BK4585","LU1778281490.HKD","SG9999015952.SGD","LU0965509101.SGD","LU1585245621.USD","BBH","MEDI","LU1934455863.HKD","BK4550","LU0058720904.USD","BK4583","GILD","IE00B3T34201.USD","IE00B19Z3581.USD","LU0320765992.SGD","IE00BSNM7G36.USD","LU1037948897.HKD","LU1066053197.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU2112291526.USD","LU0823416689.USD","BK4532","TMED","LU1037948541.HKD","LU1430594728.SGD","LU1674673691.USD","LU2087621335.USD","SG9999015978.USD","LU2324357040.USD","TBXU","LU0289739699.SGD","IE00B7SZLL34.SGD","LU0109394709.USD","LU0114720955.EUR","LU2089984988.USD","IE00BKVL7J92.USD","IBB","IBBQ","LU1674673428.USD","LU0965508806.USD","BK4578","IE00BZ1G4Q59.USD","SG9999015986.USD","BK4566","BMED","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660439442","title":"argenx SE(ARGX)股票8月17日盤中上漲16.67%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2660439442","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660439442?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 00:16","pubTimestamp":1786983373,"startTime":"0","endTime":"0","summary":"• Argenx 宣布其药物 VYVGART Hytrulo 在治疗肌炎的 3 期 ALKIVIA 研究中取得积极结果。\n• 该公司公布全年营收为 41.5 亿美元，净利润为 12.9 亿美元。\n• 分析师给予“买入”评级，平均目标价为 1083.77 美元。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262112725-market-movers-argx-20260817","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE00B4R5TH58.HKD","IE0002141913.USD","TBXU","IE0009355771.USD","BK4588","IE00BJJMRZ35.SGD","LU1983260115.SGD","LU0109394709.USD","BK4585","BK4139","LU2324357040.USD","IBB","IE00BFTCPJ56.SGD","ARGX","IE00B2B36J28.USD","FMED","BK4505","IE0034235188.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660332334","title":"EyePoint股價料將創下歷史最大跌幅，因其一款實驗性眼科藥物未能達到後期臨床試驗目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2660332334","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660332334?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 22:15","pubTimestamp":1786976114,"startTime":"0","endTime":"0","summary":"BUZZ-EyePoint股价料将创下历史最大跌幅，因其一款实验性眼科药物未能达到后期临床试验目标最新动态8月17日-**EyePoint公司（EYPT.O）股价暴跌71%至4.17美元，有望创下有史以来最大单日跌幅，并跌至2025年4月以来的最低点**这家药物开发商表示，其实验性眼科药物Duravyu在针对湿性年龄相关性黄斑变性（视力丧失的主要原因之一）患者开展的晚期临床试验中，未能达到主要目标","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0058720904.USD","LU1917777945.USD","IBB","REGN","EYPT","BK4588","LU2362541273.HKD","TBXU","BK4007","LU2106854487.HKD","BBH","LU2362540622.SGD","LU2237438978.USD","LU0114720955.EUR","LU0289739699.SGD","IBBQ","LU0823434583.USD","LU0889565916.HKD","LU0053666078.USD","LU1974910355.USD","LU0320765992.SGD","LU0823416689.USD","LU0823434740.USD","LU2468319806.SGD","LU0109394709.USD","LU0882574055.USD","LU2023250504.SGD","BK4139","LU2362541513.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137019504","title":"美股開盤 | 三大指數升跌不一，閃迪升逾3%，Argenx SE漲近9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137019504","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137019504?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 21:32","pubTimestamp":1786973544,"startTime":"0","endTime":"0","summary":"8月17日，美股三大指数开盘涨跌不一，道琼斯指数跌0.23%，标普500指数涨0.04%，纳斯达克综合指数涨0.24%。美股存储股普涨，SK海力士、西部数据、闪迪涨超3%，美光科技、希捷科技涨超2%。OmniAb涨超23%，公司此前宣布与礼来达成3.7亿美元药物研发协议。Argenx SE涨近9%，Efgartigimod治疗肌炎III期试验成功。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","LU1093756168.USD","BK4512","DIA","SG9999018865.SGD","IE00B1XK9C88.USD","SMU00main","SPYH","LU0476273544.USD","LU0882574139.USD","RXL","LU2089985449.USD","LU0061475181.USD","LU0256863902.USD","LU0889566641.SGD","SHOC","LU0432979614.USD","LU1670628061.USD","BK4527","SKHY","IE0009355771.USD","LU2471134952.CNY","SDOW","LU0096364046.USD","LU0109392836.USD","LU0471298694.HKD","SG9999017495.SGD","BK4139","TMED","LU1670627923.USD","LU2023251221.USD","LU0127658192.USD","LU0820561909.HKD","LU2111349929.HKD","LU0256863811.USD","LU0417517546.SGD","VHT","IE00BFSS7M15.SGD","LU0234572021.USD","LU0859254822.USD","LU2290526834.HKD","LU2471134523.USD","BK4516","IE00BKDWB100.SGD","PPH","LU0225283273.USD","SGXZ57979304.SGD","LU2462157665.USD","LU2417539215.USD","LU2543165471.USD","LU2931357623.SGD","IE00B19Z3B42.SGD","LLYX","LU2602419157.SGD","PJP","STX.AU","IE0002141913.USD","LU1868836591.USD","TBXU","IE00BFSS8Q28.SGD","ELIL","LU0320765059.SGD","IE0002270589.USD","LU2471134879.HKD","IE00B2B36J28.USD","USXF","LU1712237335.SGD","SG9999001424.SGD","SGXZ51526630.SGD","SPYU","LU2552382132.HKD","IE00BJT1NW94.SGD","LU2360107168.USD","BK4532","LEGR","SKHZ","CHPX","BK7142","LU2324357040.USD","IE00B19Z3581.USD","SNDK","LU0444973449.USD","ILDR","LU2237443465.HKD","RULE","XNTK","FTEC","LU2264538146.SGD","IE00BJLML261.HKD","BK4533","SNDC","ARTY","IE0034235303.USD","LU1069347547.HKD","LU0203201768.USD","LU0238689110.USD","LU0158827948.USD","FAI","LU2168564149.EUR","BK4599","MUYY","LU2237443382.USD","SG9999001176.USD","LU2236285917.USD","LU1823568750.SGD","GDOC","LU0823434583.USD","ARGX","MUD","SGXZ31699556.SGD","AGNG","TMSL","LU0058720904.USD","LU2112291526.USD","FDTX","LU0240878834.USD","FSMD","LU0133085943.USD","SH","QQQA","JGRO","SG9999014906.USD","FXL","LU2286300806.USD","SG9999013999.USD","LU1316542783.SGD","LU2237443549.SGD","LU2491050154.USD","LU0889565916.HKD","IE00B5949003.HKD","IE00BK4W5M84.HKD","TTXU","LU1917777945.USD","LU1291159041.SGD","BK4579","BOBP","LU0640476718.USD","LU1868836914.USD","LU2089984988.USD","LU1145028129.USD","LU2168563687.JPY","LU2089284900.SGD","OPTZ","SG9999014898.SGD","DISK","BK4566","IE00BJJMRZ35.SGD","LU0240877869.USD","LU0642271901.SGD","IE00BWXC8680.SGD","FMED","SOXX","SMAX","BK4553","SPDN","SSO","IE00BKPKM429.USD","IE00B7KXQ091.USD","LU1720051108.HKD","LU2028103732.USD",".DJI","LU1979441026.SGD","IE00BJJMRX11.SGD","LU0323591593.USD","IBB","LU0109394709.USD","DMAX","LU0320765992.SGD","IXJ","MU","LU0158827781.USD",".SPX","LU0708995401.HKD","LU0079474960.USD","DOG","SPYQ","EFIV","LLII","LU1061106388.HKD","LU0882574055.USD","UPRO","LU0054578231.USD","LU1674673691.USD","LU0097036916.USD","LU1861215975.USD","LU2357305700.SGD","LU0122379950.USD","SPY","SG9999015978.USD","IE00BJJMRY28.SGD","LU0683600562.USD","LU1868836757.USD","LU0072461881.USD","LU2746668461.USD","LU2403377893.USD","LU0456855351.SGD","IE00B894F039.SGD","LU0081259029.USD","LU2054465674.USD","LU0466842654.USD","LU2756315318.SGD","EMSF","LU0385154629.USD","LU2237443622.USD","BAI","SPUU","LU1815336760.USD","SPXS","AIQ","LU0889565833.HKD","LU0354030511.USD","IVV","LU1983299246.USD","IE00B1BXHZ80.USD","LU0203345920.USD","LU0198837287.USD","LU1127390331.HKD","LU0109391861.USD","LU1803068979.SGD","BK4170","LU0957808578.USD","WLDR","LU2491050071.SGD","LU2023250504.SGD","CURE","LU2746668974.SGD","SG9999001176.SGD","LU2361045086.USD","SK","LU0689472784.USD","AIFD","LU0056508442.USD","LU0006306889.USD","LU0353189763.USD","LU1623119135.USD","IE00B4JS1V06.HKD","TRUH","LU0094547139.USD","LU2756315664.SGD","LU2106854487.HKD","SG9999015986.USD","07709","LU0082616367.USD","LU0823416689.USD","LU2089283258.USD","LU0154236417.USD","LU0006061336.USD","BK4581","LU0345770993.USD","LU1989771016.USD","LU2458330169.SGD","LU1064131342.USD","LU2360106947.USD","LU2552382058.USD","CNEQ","SG9999014880.SGD","IHE","LU2491049909.HKD","LU0820561818.USD","CGGO","PTF","CHPS","BK4534","LU0719512351.SGD","LU1035773651.USD","LU2108987350.USD","LU2357627491.SGD","LU2361044949.HKD","OZEM","QQQG","LU1232071149.USD","LU1093756325.SGD","BK4588","SKUU","SG9999014914.USD","LU0289739699.SGD","LU2360106780.USD","LU0316494557.USD","JDOC","LU2023250330.USD","LU0114720955.EUR","LU0274383776.USD","GB00BDT5M118.USD","SDS","ELIS","LU0345770308.USD","LU1267930730.SGD","LU1814569148.SGD","IE000M9KFDE8.USD","WDC","LU0354030438.USD","LU1852331112.SGD","VOO","BK4543","LU2750360641.GBP","LU1046421795.USD","LU0786609619.USD","LU1989764748.USD","LU1804176565.USD","IETC","LU2087625088.SGD","LU2237443978.SGD","SNXX","SCHM","YSPY","SKHU","LU1642822529.SGD","LU1551013342.USD","MEDX","LU2063271972.USD","LU0174119429.USD","WUGI","SNDU","IE00BSNM7G36.USD","HRTS","DDM","IE0001KFT4U8.USD","LU1548497426.USD","LU0672654240.SGD","LU2552382215.SGD","LU1366333091.USD","HIBL","PSI","EGGY","IE0004445015.USD","LU0203202063.USD","CNAV","LU2168564065.EUR","SNDQ","LU1720051017.SGD","FTXL","LU2271345857.HKD","BK4585","SKHX","CHAT","LU0353189680.USD","LU1069344957.HKD","LU2462591350.SGD","IE00B19Z9P08.USD","LU2213496289.HKD","SPYM","MULL","LU2237443895.HKD","SMH","BK4554","IE00BN29S564.USD","LU1778281490.HKD","SPXL","COWG","LU2456880835.USD","IE00B7SZLL34.SGD","SOXQ","XLK","FTXH","LU1988902786.USD","WDNA","LU2168564222.USD","LU2471134796.USD","LU2750360997.AUD","WDCX","LU2896262040.SGD","LU0210536198.USD","LU2048586759.USD","SG9999018857.SGD","LU2458330243.SGD","LU1366192091.USD","DXD","LU0203347892.USD","SPXU","BK4575","IE00B4R5TH58.HKD","LU0963586101.USD","MUU","IXN","MIC","LU0820562030.AUD","LU0823434740.USD","LLY","LU2250418816.HKD","LU1868837300.USD","LU0444971666.USD","SGXZ99366536.SGD","STX","IE0004445239.USD","MHIP","AIS","LU1280957306.USD","LU0964807845.USD","VGT","LU0943347566.SGD","IE00BFTCPJ56.SGD","LU1323610961.USD","FCUS","LU2168564495.EUR","TRFK","LU0266013472.USD","LU2211815571.USD","IE0009356076.USD","CANC","FHLC","SKHA","SGXZ81514606.USD","LLYZ","MMAX","THNR","LU1674673428.USD","LU2265009873.SGD","LU0106261372.USD","LU1914381329.SGD","BK4605","IE0034235188.USD","MUZ","LU1267930813.SGD","LU0787776722.HKD","LU1057294990.SGD","XLV","YMmain","LU2102340556.USD","SKHYV","DRMY","LU2461242641.AUD","IE00BK4W5L77.USD","LU1989764664.SGD","SG9999015945.SGD","LU2361044865.SGD","MEDI","LU1023059063.AUD","LU1974910355.USD","BK4141","LU0471298777.SGD","BK4007","LU1551013425.SGD","LU1983260115.SGD","LU2237438978.USD","LU0157215616.USD","LU2468319806.SGD","HYNX","LU0792757196.USD","UDOW","LU1235294995.USD","HBMX","BK4505","SNDG","SCHA","IE00B19Z9Z06.USD","LU1035775433.USD","SG9999015952.SGD","LU1629891620.HKD","LU1861220033.SGD","IE0005OL40V9.USD","LU1868837136.USD","IYH","IE00B775H168.HKD","SKDD","LU0162691827.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":150,"code":"91000000","status":"200"}]}}